Back
ENDRA Life Sciences 10K Form
Sell
35
NDRA
ENDRA Life Sciences
Last Price:
0.31
Seasonality Move:
12.64%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-14 | 10Q | NDRA/ENDRA Life Sciences Quarterly |
| 2020-05-14 | 10Q | NDRA/ENDRA Life Sciences Quarterly |
| 2020-03-26 | 10K | NDRA/ENDRA Life Sciences Annual |
| 2019-11-13 | 10Q | NDRA/ENDRA Life Sciences Quarterly |
| 2019-08-08 | 10Q | NDRA/ENDRA Life Sciences Quarterly |
| 2019-05-14 | 10Q | NDRA/ENDRA Life Sciences Quarterly |
Receive NDRA News And Ratings
See the #1 stock for the next 7 days that we like better than NDRA
NDRA Financial Statistics
Sales & Book Value
| Annual Sales: | $6.17K |
|---|---|
| Cash Flow: | $-2.18M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.54 |
| Price / Book: | 0.6 |
Profitability
| EPS (TTM): | -1.81000 |
|---|---|
| Net Income (TTM): | $-10.06M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
ENDRA Life Sciences Earnings Forecast
Key ENDRA Life Sciences Financial Ratios
- The Selling, General & Administrative Expenses for NDRA have been equal to 65,075.85% of Gross Profit Margin.
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 10 years have been positive in 5 years.
ENDRA Life Sciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | NDRA |
| CUSIP: | 29273B |
| Website: | endrainc.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NDRA Technical Analysis vs Fundamental Analysis
Sell
35
ENDRA Life Sciences (NDRA)
is a Sell
Is ENDRA Life Sciences a Buy or a Sell?
-
ENDRA Life Sciences stock is rated a Sell
The current ENDRA Life Sciences [NDRA] share price is $0.31. The Score for NDRA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.